at 02:05 |
|
|
AstraZeneca:
Revenue and EPS summary
Q1 2024
% Change
$m
Actual
CER1
- Product Sales
12,177
15
18
- Alliance Revenue
457
59
59...
|
at 02:00 |
|
|
Galantas Gold Corporation (the ?Company') is pleased to announce its audited annual financial results for the year ended December 31, 2023. A copy of the Financial Statements and Management Discussion and Analysis will be sent to shareholders in due...
|
at 02:00 |
|
|
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com.
The earnings release can be found at...
|
at 02:00 |
|
|
ICEYE, a global leader in satellite-powered disaster management solutions, has announced a new data collaboration with Juniper Re, LLC ("Juniper Re"), the dynamic reinsurance broking arm and indirect subsidiary of BRP Group, Inc. .
Juniper Re will...
|
at 02:00 |
|
|
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...
|
at 01:54 |
|
|
Continuous efforts to improve profits, competitiveness, and cash flowQ1/2024 (year-on-year)
Sales decreased by 20% to EUR 2,164 (2,721) million.Adjusted EBIT decreased to EUR 156 (234) million.Adjusted EBIT margin was 7.2% (8.6%).Operating result...
|
|
|